FONAR CORPORATION (FONR) valuation

Bring your own price

Enter a share price and a discount rate — every multiple, the earning-power value and the reverse-DCF below recompute on the spot from FONAR CORPORATION's latest SEC EDGAR filings. Change either input and the whole page follows.

$
%
Enter a share price to run the model.

The prefilled 8.9% is a plain CAPM cost of equity at β = 1: the 10-year Treasury yield (4.46%, 2026-06-18, U.S. Treasury 10-yr) plus the U.S. equity risk premium (4.46%, Damodaran 2026-01-01). Build a firmer per-company rate with the cost-of-equity and WACC calculators, then paste it here.

Share price · awaiting your input

Market Capitalization

Equity value at your price

Price-to-Earnings

P/E · Trailing Diluted

Earnings Yield

EPS ÷ Price · Trailing

Price-to-Free-Cash-Flow

P/FCF · Trailing

Free-Cash-Flow Yield

FCF Yield · Trailing

Price-to-Sales

P/S · Trailing

Price-to-Book

P/B · Latest filing

Fundamentals from the filings

Every model input below comes straight from FONAR CORPORATION's SEC EDGAR XBRL filings — these are the denominators and bridge inputs the calculator pairs with your price and rate.

Trailing twelve months · TTM as of 2026-03-31 (Q3 FY2026)

Revenue
$105.3M
EBIT (GAAP)
$11.4M
EBIT margin
10.8%
Operating cash flow
$7.7M
CapEx
$3.1M
Free cash flow
$4.6M
YoY revenue growth
2.3%

CapEx bundles PP&E purchases + capitalised software/intangibles ($1.3K) — the same total the P/FCF and FCF-Yield cards net against operating cash flow.

Balance sheet · 10-Q · period ending 2026-03-31

Cash & investments
$53.8M
Total debt
$38.8M
Stockholders' equity
$178.6M
Excess cash
$51.7M

Total debt = Operating lease liability ($38.6M) + Finance lease liability ($224.0K) .

Excess cash = total cash − an operating-cash floor of 2% of TTM revenue ($2.1M) that a buyer couldn't pocket without starving operations.

Share count

Diluted shares (TSM-scaled)
6.9M
Earning-Power-Value, reverse-DCF, and EV/EBITDA are hidden for this insurer. EPV and the reverse-DCF both anchor on an EBIT margin, but a insurer's "margin" is interest-spread × leverage with non-EBIT investment results mixed in; EV/EBITDA omits deposits and borrowings — the actual funding — so the multiple isn't interpretable. The trailing multiples above (P/E, P/S, P/B, P/FCF) still render, but the right lens here is price-to-tangible-book-value and ROE vs cost of equity — applied manually, outside this page.

What these ratios mean & how they're built: see the valuation ratios glossary on the Financials methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Fundamentals come from SEC EDGAR XBRL filings for FONR (CIK 0000355019). The share price and the discount rate are inputs you supply — nothing on this page is a market quote, and the page fetches no market data. Per-share denominators are split-adjusted to today's share count.

Related tickers

PHBI

PHARMAGREEN BIOTECH INC.

AFCG

ADVANCED FLOWER CAPITAL INC.

FWRD

FORWARD AIR CORPORATION